|
Synonyms: Benlysta® | hBlySmAb-1.1 | LimphoStat-B | lymphostat-B
belimumab is an approved drug (FDA (2011), EMA (2011))
Compound class:
Antibody
|
| Immunopharmacology Comments |
| Suppresses B-cell mediated immunity in autoimmune diseases. |
| Immunopharmacology Disease | |||
| Disease | X-Refs | Comment | References |
| Systemic lupus erythematosus |
Disease Ontology:
DOID:9074 OMIM: 152700 Orphanet: ORPHA536 |
Approved drug for SLE. | |
| Sjögren's syndrome |
Orphanet:
ORPHA378 |
In clinical trial for this indication- see NCT02631538, in combination with rituximab. | |
| Vasculitis |
Disease Ontology:
DOID:865 |
In clinical trial for this indication- see NCT01663623. | |
| Myositis |
Disease Ontology:
DOID:633 OMIM: 160750 |
In clinical trial for this indication- see NCT02347891. | |